A Systematic Review of Lifestyle Interventions for Neuropathy and Neuropathic Pain: Smoking Cessation
Authors:
- Michael KlowakMKMichael Klowak
- Rachel LauRLRachel Lau
- Mariyam N. MohammedMMMariyam N. Mohammed
- Afia BiragoABAfia Birago
- Bethel SamsonBSBethel Samson
- Layla AhmedLALayla Ahmed
- Camille ReneeCRCamille Renee
- Milca MeconnenMMMilca Meconnen
- Ezra BadoEBEzra Bado
- Aquilla Reid-JohnARAquilla Reid-John
- Andrea K. BoggildABAndrea K. Boggild
Open Access
Abstract
Background: Neuropathic pain (NP), resulting from damage to the somatosensory nervous system, affects 7–10% of the global population and remains poorly managed despite available therapies. Smoking has been associated with increased pain severity and disease burden, yet its role in neuropathy/NP has not been systematically reviewed. This systematic review synthesizes the existing literature on smoking status and its relationship with neuropathy/NP incidence, prevalence, and severity. Methods: The review was conducted in accordance with PRISMA guidelines and included studies that assessed smoking consumption, dependency, quantity, and cessation in individuals with neuropathy/NP. Summary estimates were stratified by exposure type, and pooled odds ratios and relative risks were calculated. Results: Across 62 studies comprising cohort, case–control, and cross-sectional designs, smoking was consistently associated with greater NP prevalence and pain severity. Smoking dependency was linked to increased incidence, while cessation was associated with reduced risk of NP. Despite considerable heterogeneity and risk of bias, particularly from subjective exposure measurement and inconsistent classification, this relationship remained statistically significant. Conclusions: Findings support the role of smoking as a modifiable risk factor in various etiologies of neuropathy/NP. Cessation may represent a low-cost, low-risk, low-tech adjunctive therapy; however, further robust cessation interventional trials are needed, particularly for less common infectious causes of chronic NP such as leprosy.Keywords
Funding Information
- Departments of Medicine at the University of Toronto
- University Health Network
- Queen Elizabeth II Graduate Scholarship in Science and Technology
- Institute of Medical Science at the University of Toronto
This publication has 86 references indexed in Scilit:
- Changes in smoking status, amount of smoking and their relation to the risk of microvascular complications in men with diabetes mellitusDiabetes/Metabolism Research and Reviews, 2023
- Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in ChinaDiabetes/Metabolism Research and Reviews, 2023
- Pain, disability, and lifestyle: Patients with complex regional pain syndrome compared to chronic musculoskeletal pain—A retrospective analysisEuropean journal of pain, 2021
- Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomesCancer Medicine, 2021
- Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht StudyDiabetologia, 2020
- Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetesDiabetes/Metabolism Research and Reviews, 2014
- Lifestyle risk factors for ulnar neuropathy and ulnar neuropathy‐like symptomsMuscle & Nerve, 2013
- Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications StudyDiabetologia, 1996
- Nerve function and its determinants in patients with newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus and in control subjects ? a 5-year follow-upDiabetologia, 1993
- Subclinical Neuropathy Associated With Chronic Obstructive Pulmonary DiseaseArchives of Neurology, 1981